Literature DB >> 2200804

Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle.

S E Litwin1, T E Raya, P G Anderson, S Daugherty, S Goldman.   

Abstract

To provide an integrated assessment of changes in systolic and diastolic function in diabetic rats, we measured conscious hemodynamics and performed ex vivo analysis of left ventricular passive-elastic properties. Rats given streptozotocin (STZ) 65 mg/kg i.v. (n = 14) were compared with untreated age-matched controls (n = 15) and rats treated with insulin after administration of STZ (n = 11). After 7 d, diabetic rats exhibited decreases in heart rate and peak developed left ventricular (LV) pressure during aortic occlusion. After 26 d of diabetes there were significant decreases in resting LV systolic pressure, developed pressure, and maximal +dP/dt, whereas LV end-diastolic pressure increased and the time constant of LV relaxation was prolonged. The passive LV pressure-volume relationship was progressively shifted away from the pressure axis, and the overall chamber stiffness constant was decreased. However, "operating chamber stiffness" calculated at end-diastolic pressure was increased at 7 d, and unchanged at 26 d. LV cavity/wall volume and end-diastolic volume were increased after 26 d of diabetes. Myocardial stiffness was unchanged at both time intervals. All of the above abnormalities were reversed by the administration of insulin. We conclude that the hemodynamic and passive-elastic changes that occur in diabetic rats represent an early dilated cardiomyopathy which is reversible with insulin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200804      PMCID: PMC296750          DOI: 10.1172/JCI114734

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Evidence for cardiomyopathy in familial diabetes mellitus.

Authors:  T J Regan; M M Lyons; S S Ahmed; G E Levinson; H A Oldewurtel; M R Ahmad; B Haider
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

2.  Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.

Authors:  J L Weiss; J W Frederiksen; M L Weisfeldt
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

3.  Insulin prevention of altered muscarinic receptor-G protein coupling in diabetic rat atria.

Authors:  R S Aronstam; G O Carrier
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

4.  Evaluation of left ventricular diastolic function.

Authors:  W Y Lew
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

5.  Role of diabetes in congestive heart failure: the Framingham study.

Authors:  W B Kannel; M Hjortland; W P Castelli
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

6.  Relation between mechanics of contraction and relaxation in mammalian cardiac muscle.

Authors:  W W Parmley; E H Sonnenblick
Journal:  Am J Physiol       Date:  1969-05

7.  Diabetes mellitus induces changes in cardiac myosin of the rat.

Authors:  W H Dillmann
Journal:  Diabetes       Date:  1980-07       Impact factor: 9.461

8.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

Authors:  P H Stone; J E Muller; T Hartwell; B J York; J D Rutherford; C B Parker; Z G Turi; H W Strauss; J T Willerson; T Robertson
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

9.  The effect of diabetes on performance and metabolism of rat hearts.

Authors:  S Penpargkul; T Schaible; T Yipintsoi; J Scheuer
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

10.  Collagen metabolism in the myocardium from streptozotocin-diabetic rats.

Authors:  J Modrak
Journal:  Diabetes       Date:  1980-07       Impact factor: 9.461

View more
  38 in total

Review 1.  Hyperglycemia and heart dysfunction: an oxidant mechanism contributing to heart failure in diabetes.

Authors:  K Esposito; R Marfella; D Giugliano
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

2.  Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy.

Authors:  N Kaul; N Siveski-Iliskovic; M Hill; N Khaper; C Seneviratne; P K Singal
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 3.  Cardiomyopathy associated with noninsulin-dependent diabetes.

Authors:  S W Schaffer
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

4.  Increased myocardial short-range forces in a rodent model of diabetes reflect elevated content of β myosin heavy chain.

Authors:  Charles S Chung; Mihail I Mitov; Leigh Ann Callahan; Kenneth S Campbell
Journal:  Arch Biochem Biophys       Date:  2013-09-04       Impact factor: 4.013

5.  Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2017-12-20       Impact factor: 4.432

6.  Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice.

Authors:  Marco Meloni; Betty Descamps; Andrea Caporali; Lorena Zentilin; Ilaria Floris; Mauro Giacca; Costanza Emanueli
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

7.  Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.

Authors:  Leni Vandekerckhove; Zarha Vermeulen; Zhi Zhao Liu; Sonia Boimvaser; Andreas Patzak; Vincent F M Segers; Gilles W De Keulenaer
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-19       Impact factor: 4.310

8.  The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus.

Authors:  T Radovits; T Bömicke; G Kökény; R Arif; S Loganathan; K Kécsán; S Korkmaz; E Barnucz; P Sandner; M Karck; G Szabó
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

9.  Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats.

Authors:  F Saito; M Kawaguchi; J Izumida; T Asakura; K Maehara; Y Maruyama
Journal:  Diabetologia       Date:  2003-07-11       Impact factor: 10.122

Review 10.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.